Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Ginkgo Bioworks announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium ...

AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

Prescient investors who participated in Immaterial’s £13.5million Series A2 funding round will be delighted that the advanced ...

Learn more about whether BioMarin Pharmaceutical Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

AWMA®, APMA®, CRPC®, AWMA®, ABFP®, investment advisor representative at Retirement Income Source® SFG, has been recognized by InvestmentNews as the Orion Award winner for Rising Star Advisor of ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...

Prof Fairen-Jimenez, CSO of Vector Bioscience Cambridge and Professor of Molecular Engineering at the University of Cambridge ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

(Alliance News) - Genflow Biosciences PLC on Monday reported progress towards full protection of its longevity gene therapy platform. The company said the European Patent Office has recognised the ...